Reduction in Physician Reimbursement and Use of Hormone Therapy in Prostate Cancer
Reads0
Chats0
TLDR
The 2003 Medicare Modernization Act reduced reimbursements for AST by 64% between 2004 and 2005, but the effect of this large reduction on use of AST in prostate cancer is unknown.Abstract:
Background
Use of androgen suppression therapy (AST) in prostate cancer increased more than threefold from 1991 to 1999. The 2003 Medicare Modernization Act reduced reimbursements for AST by 64% between 2004 and 2005, but the effect of this large reduction on use of AST is unknown.read more
Citations
More filters
Journal ArticleDOI
Comparison of SEER Treatment Data With Medicare Claims
Anne-Michelle Noone,Jennifer L. Lund,Angela B. Mariotto,Kathleen A. Cronin,Timothy S. McNeel,Dennis Deapen,Joan L. Warren +6 more
TL;DR: SEER data should not generally be used for comparisons of treated and untreated individuals or to estimate the proportion of treated individuals in the population, andAugmenting SEER data with other data sources will provide the most accurate treatment information.
Journal ArticleDOI
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer
Journal ArticleDOI
Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US.
Katherine E Mues,Alexander Liede,Jiannong Liu,James B. Wetmore,Rebecca Zaha,Brian D. Bradbury,Allan J. Collins,David T. Gilbertson +7 more
TL;DR: A summary of Medicare data is provided, including the types of data that are captured, and how they may be used in epidemiologic and health outcomes research, to highlight strengths, limitations, and key considerations when designing a study using Medicare data.
Journal ArticleDOI
Pharmaceutical policies: effects of financial incentives for prescribers
TL;DR: The effects of pharmaceutical policies using financial incentives to influence prescribers' practices on drug use, healthcare utilisation, health outcomes and costs are determined and pay for performance policies are evaluated.
References
More filters
Journal ArticleDOI
Does Reimbursement Influence Chemotherapy Treatment For Cancer Patients
Mireille Jacobson,A. James O'Malley,Craig C. Earle,Juliana Pakes,Peter Gaccione,Joseph P. Newhouse +5 more
TL;DR: The effect of physician reimbursement on chemotherapy treatment of Medicare beneficiaries older than age sixty-five with metastatic lung, breast, colorectal, or other gastrointestinal cancers between 1995 and 1998 is examined.
Journal ArticleDOI
A structured debate: immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment.
TL;DR: It is shown that immediate hormonal intervention has not been conclusively shown to provide a survival advantage in the management of advanced prostate cancer, and delayed treatment is recommended in men with biochemical relapse following surgery or radiotherapy.
Journal ArticleDOI
Dartmouth Atlas of Health Care
TL;DR: It is not wholly fanciful to compare the Dartmouth Atlas of Health Care with On the Origin of Species .
Journal ArticleDOI
Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population.
TL;DR: Changes in reimbursement related to the use of medical androgen deprivation led in part to the Medicare Modernization Act in 2003 and it is hypothesized that these changes in reimbursement may affect the way practitioners administer these treatments.
Journal ArticleDOI
Lack of Physician Concordance With Guidelines on the Perioperative Use of β-Blockers
TL;DR: Perioperative beta-blocker therapy is underutilized in patients with risk factors for coronary artery disease despite evidence that its use in appropriate individuals may be lifesaving.